Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Infection and Chemotherapy ; : 257-266, 2016.
Article Dans Anglais | WPRIM | ID: wpr-179932

Résumé

The pneumococcal conjugate vaccine (PCV) was developed to overcome the limitations of the pneumococcal polysaccharide vaccine, which produces poor immunogenicity in infants younger than 2 years. As many countries have included PCVs in national immunization programs for children, the incidence of invasive pneumococcal disease caused by vaccine type Streptococcus pneumoniae has declined markedly, not only among the vaccinated pediatric population, but also among unvaccinated adults. In this review, we present a concise overview of the indirect effects of mass pediatric PCV immunization on unvaccinated adults.


Sujets)
Adulte , Enfant , Humains , Nourrisson , Programmes de vaccination , Immunisation , Incidence , Vaccination de masse , Infections à pneumocoques , Vaccins antipneumococciques , Streptococcus pneumoniae , Vaccins conjugués
SÉLECTION CITATIONS
Détails de la recherche